Description of Research Expertise:
Prostate Cancer
Renal Cell Carcinoma/Kidney Cancer
Bladder Cancer
Selected Publications:
Narayan, V.; Puligandla, M.; Haas, NB.; Subramanian, P.; DiPaola, RS.; Uzzo, R.: Patterns of Relapse and Implications for Post-Nephrectomy Surveillance for Patients with High-Risk Non-Clear Cell Renal Cell Carcinoma: Subgroup Analysis of the Phase 3 ECOG-ACRIN E2805 Trial J Urol 201 (1): 62-68,2019.
Narayan, V.; Keefe, S.; Haas, NB.; Wang, L.; Puzanov, I.; Putt, M.; Catino, A.; Fang, J.; Agarwal, N.; Hyman, D.; Smith, AM.; Finkelman, B.; Narayan, HK.; Ewer, S.; ElAmm, C.; Lenihan, D.; Ky, B.: Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma Clin Cancer Res 23 (14): 3601-3609,2017.
Chanzá, NM.; Xie, W.; Bilen, MA.; Dzimitrowicz, H.; Burkart, J.; Geynisman, DM.; Balakrishnan, A.; Bowman, IA.; Jain, R.; Stadler, W.; Zakharia, Y.; Narayan, V.; Beuselinck, B.; McKay, R.; Tripathi, A.; Pachynski, R.; Hahn, AW.; Hsu, J.; Shah, SA.; Lam, ET.; Rose, TL.; Mega, AE.; Vogelzang, N.; Harrison, MR.; Mortazavi, A.; Plimack, ER.; Vaishampayan, U.; Hammers, H.; George, S.; Haas, N.; Agarwal, N.; Pal, SK.; Srinivas, S.; Carneiro, BA.; Heng, D.; Bosse, D.; Choueiri, T.; Harshman, LC.: Cabozantinib in advanced non-clear cell renal carcinoma: a multicenter retrospective cohort analysis Lancet Oncol 20 (4): 581-590,2019.
Narayan, V.; Ky, B.: Common Cardiovascular Complications of Cancer Therapy: Epidemiology, Risk Prediction, and Prevention Annu Rev Med 69 (1): 97-111,2018.
Finkelman, BS., Putt, M., Wang, T., Wang, L., Narayan, H., Domchek, S., DeMichele, A., Fox, K., Matro, J., Shah, P., Clark, A., Bradbury, A., Narayan, V., Carver, J., Tang, WH., Ky, B.: Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients with Breast Cancer J Am Coll Cardiology 70 (2): 152-162,2017.
Narayan, V.; Vapiwala, N.; Mick, R.; Subramanian, P.; Christodouleas, J.; Bekelman, J.; Deville, C.; Rajendran, R.; Haas, NB.: Phase I Trial of Everolimus and Radiation Therapy for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy Int J Radiat Oncol Biol Phys 97 (2): 355-361,2017.
Demissei, B.; Finkelman, B.; Hubbard, RA.; Zhang, L.; Smith, AM.; Sheline, K.; McDonald, C.; Narayan, HK.; Narayan, V.; Waxman, AJ.; Domchek, S.; DeMichele, A.; Shah, P.; Clark, A.; Bradbury, A.; Carver, J.; Upshaw, J.; Armenian, SH.; Liu, P.; Ky, B.: Detailed Phenotyping Reveals Distinct Trajectories of Cardiovascular Function and Symptoms with Exposure to Modern Breast Cancer Therapy Cancer
doi: 10.1002/cncr.32149. : 2019.
Mohiuddin, J.; Narayan, V.; Venigalla, S.; Vapiwala, N.: Variations in patterns of concurrent androgen deprivation therapy use based on dose escalation with external beam radiotherapy vs. brachytherapy boost for prostate cancer Brachytherapy
doi: 10.1016 : 2019.
Narayan, V.; Gunnarsson, O.; Hwang, WT.; Nathanson, KL.; Stadtmauer, EA.; Vaughn, DJ.: Risk-Stratified Initial Salvage Therapy for Relapsed or Refractory Metastatic Germ Cell Tumor Clin Genitourin Cancer 14 (6): 524-529,2016.
Narayan, V., Haas, N.: Axitinib in the treatment of renal cell carcinoma: patient selection and perspectives Int J Nephrol 9 : 65-72,2016.
Demissei BG; Finkelman B; Hubbard RA; Smith AM; Narayan HK; Narayan V; Shah P; Waxman AJ; Domchek SM; Ky B.: Cardiovascular Function Phenotypes in Response to Cardiotoxic Breast Cancer Therapy J Am Coll Cardiology 73 (2): 248-249,2019.
Zhang, KW; Finkelman, BS; Gulati, G; Narayan, HK; Upshaw, J; Narayan, V; Plappert, T; Englefield, V; Smith, AM; Zhang, C; Hundley, WG; Ky B.: Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction JACC Cardiovasc Imaging
11 (8): 1059-1068,2018.
Narayan, V.; Hwang, WT.; Lal, P.; Rosen, M.; Gallagher, M.; O'Dwyer, P.; Vaughn, DJ.: Cyclin-Dependent Kinase 4/6 Inhibition for the Treatment of Mature Teratoma: Long-term Follow-up of a Phase II Study Clin Genitourin Cancer 14 (6): 504-510,2016.
Narayan, V.; Deshpande, C.; Bermudez, CA.; Golato, JM.; Lee, J.; Diamond, J.; Vaughn, DJ.: Bilateral Lung Transplantation for Bleomycin-Associated Lung Injury Oncologist 22 (5): 620-622,2017.
Narayan, V.; Mamtani, R.; Keefe, S.; Guzzo, T.; Malkowicz, SB.; Vaughn, DJ.: A Phase II Study of Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer Cancer Res Treat 48 (3): 1084-91,2016.
Feld, E.; Harton, J.; Meropol, NJ.; Adamson, BJS.; Cohen, A.; Parikh, RB.; Galsky, MD.; Narayan, V.; Christodouleas, J.; Vaughn, DJ.; Hubbard, RA.; Mamtani, R.: Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial Cancer Eur Urol pii: S0302-2838(19)30591-3. : 2019.
Narayan, V.; Vaughn, DJ.; Ky, B.: Cardiovascular Toxicities of Therapy for Genitourinary Malignancies Urologic Oncology: Seminars and Original Investigations doi: 10.1016/j.urolonc.2019 : 2019.
Sharma, P.; Pachynski, R.; Narayan, V.; Flechon, A.; Gravis, G.; Galsky, M.; Mahammedi, H.; Patnaik, A.; Subudhi, S.; Ciprotti, M.; Duan, T.; Saci, A.; Hu, S.; Han, GC.; Fizazi, K.: Initial results from a phase II study of nivolumab (NIVO) plus ipilimumab (IPI) for the treatment of metastatic castration-resistant prostate cancer (mCRPC; CheckMate 650) American Society of Clinical Oncology Genitourinary Cancers Symposium, San Francisco, CA J Clin Oncol 37 (suppl 7S; abstr 142): 2019.
Narayan, V.; Gladney, W.; Plesa, G.; Vapiwala, N.; Carpenter, E.; Maude, SL.; Lal, P.; Lacey, S.; Melenhorst, J.; Sebro, R.; Farwell, M.; Hwang, WT.; Moniak, M.; Gilmore, J.; Lledo, L.; Dengel, K.; Marshall, A.; Coughlin, C.; June, CH.; Haas, NB.: A phase I clinical trial of PSMA-directed/TGFβ-insensitive CAR-T cells in metastatic castration-resistant prostate cancer American Society of Clinical Oncology Genitourinary Cancers Symposium, San Francisco, CA J Clin Oncol 37 (suppl 7S; abstr TPS347): 2019.
Narayan, V.: Metastatic Prostate Cancer Radiation Oncology: A Question Based Review 3rd Edition : 2018.
Narayan, V.; Vaughn, D.: Pharmacokinetic and toxicity considerations in the use of neoadjuvant chemotherapy for bladder cancer Expert Opin Drug Metab Toxicol 11 (5): 731-42,2015.
Osterman, CK.; Babu, DS.; Geynisman, D.; Lewis, B.; Somerd, RA.; Balar, AV.; Zibelman, MR.; Guancial, EA.; Antinori, G.; Yu, S.; Narayan, V.; Guzzo, TJ.; Plimack, ER.; Vaughn, DJ.; Fung, C.; Mamtani, R.: Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin‐Based Chemotherapy for Muscle‐Invasive Bladder Cancer Oncologist
24 (5): 688-90,2019.
Osterman, CK.; Alanzi, J.; Lewis, JD.; Kaufman, EL.; Narayan, V.; Boursi, B.; Vajravelu, RK.; Scott, FI.; Malkowicz, SB.; Mamtani, R.: Association Between Symptomatic Versus Asymptomatic Recurrence and Survival in Bladder Cancer Clin Genitourin Cancer 16 (3): 235-239,2018.
Catino, AB; Hubbard, RA; Chirinos, JA; Townsend, R; Keefe, S; Haas, NB; Puzanov, I; Fang, JC; Agarwal, N; Hyman, D; Smith, AM; Gordon, M; Plappert, T; Englefield, V; Narayan, V; Ewer, S; ElAmm, C; Lenihan, D; Ky, B.: Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma Circ Heart Fail 11 (3): e004408,2018.
Li, L.; Huang, L.; Vergis, A.; Ye, H.; Bajwa, A.; Narayan, V.; Strieter, R.; Rosin, D.; Okusa, M.: IL-17 produced by neutrophils regulates interferon gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury J Clin Invest 120 (1): 331-42,2010.
Hwang, A.; Narayan, V.; Yang, YX.: Type 2 Diabetes Mellitus and Survival in Pancreatic Adenocarcinoma: A Retrospective Cohort Study Cancer 119 (2): 404-10,2013.
Chao, HH.; Feld, EK.; Narayan, V.; Sebro, R.; Jones, JA.: Radiation Recall Myositis Following Carboplatin/Docetaxel Chemotherapy Pract Radiat Oncol doi: 10.1016/j.prro.2019 : 2019.
Taku, N.; Narayan, V.; Wang, X.; Vapiwala, N.: Prevalence, predictors, and implications for appropriate use of active surveillance management among black men diagnosed with low-risk prostate cancer Am J Clin Oncol
42 (6): 507-511,2019.